We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+13.9%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$9.44B
AUM Growth
+$853M
(+9.9%)
Cap. Flow
-$60.5M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
10.02%
Holding
2,631
New
740
Increased
757
Reduced
599
Closed
531
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$117M |
| 2 |
McDonald's
MCD
|
+$81.3M |
| 3 |
Starbucks
SBUX
|
+$76.4M |
| 4 |
Ulta Beauty
ULTA
|
+$73.9M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
+$62.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$624M |
| 2 |
AGN
Allergan plc
AGN
|
+$85.5M |
| 3 |
Nike
NKE
|
+$81.1M |
| 4 |
TJX Companies
TJX
|
+$78.7M |
| 5 |
Constellation Brands
STZ
|
+$58.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.43% |
| 2 | Technology | 13.47% |
| 3 | Healthcare | 11.62% |
| 4 | Industrials | 9.96% |
| 5 | Financials | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
BioCryst Pharmaceuticals
BCRX
$2.37B
| $914K | 0.01% |
112,245
+65,055
| +138% | +$557K |
|
1152
Arrow Electronics
ARW
$10.9B
| $912K | 0.01% |
+11,835
| New | +$908K |
|
1153
Check Point Software Technologies
CHKP
$13.3B
| $910K | 0.01% |
7,191
+2,491
| +53% | +$290K |
|
1154
Albany International
AIN
$2.14B
| $907K | 0.01% |
12,666
+7,014
| +124% | +$500K |
|
|
BRSP
1155
BrightSpire Capital
BRSP
$681M
| $907K | 0.01% |
+57,940
| New | +$953K |
|
1156
Akebia Therapeutics
AKBA
$327M
| $905K | 0.01% |
110,542
-47,463
| -30% | -$326K |
|
1157
Columbus McKinnon
CMCO
$465M
| $905K | 0.01% |
26,350
+16,786
| +176% | +$584K |
|
1158
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $904K | 0.01% |
+34,317
| New | +$963K |
|
1159
Ciena
CIEN
$55.3B
| $902K | 0.01% |
24,161
+1,508
| +7% | +$58.6K |
|
|
APLS
1160
DELISTED
Apellis Pharmaceuticals
APLS
| $899K | 0.01% |
46,111
+3,207
| +7% | +$50.4K |
|
1161
McGrath RentCorp
MGRC
$2.94B
| $899K | 0.01% |
15,894
+4,167
| +36% | +$223K |
|
1162
Dycom Industries
DY
$12.9B
| $897K | 0.01% |
19,516
-25,250
| -56% | -$1.38M |
|
1163
Hilltop Holdings
HTH
$2.29B
| $897K | 0.01% |
+49,162
| New | +$913K |
|
1164
Cemex
CX
$17.4B
| $894K | 0.01% |
192,728
+177,154
| +1,137% | +$886K |
|
|
CURO
1165
DELISTED
CURO Group Holdings Corp.
CURO
| $894K | 0.01% |
89,117
+71,370
| +402% | +$778K |
|
1166
Phibro Animal Health
PAHC
$1.38B
| $888K | 0.01% |
26,904
-564
| -2% | -$17.6K |
|
|
ARNA
1167
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $888K | 0.01% |
19,807
+6,993
| +55% | +$321K |
|
1168
Rigel Pharmaceuticals
RIGL
$680M
| $883K | 0.01% |
34,371
+32,754
| +2,026% | +$749K |
|
1169
CALL
iShares MSCI Brazil ETF
EWZ
$9.05B
| $881K | 0.01% |
+21,500
| New | +$924K |
|
|
1170
PUT
iShares MSCI Brazil ETF
EWZ
$9.05B
| $881K | 0.01% |
+21,500
| New | +$924K |
|
1171
Mettler-Toledo International
MTD
$26.8B
| $878K | 0.01% |
+1,214
| New | +$789K |
|
1172
Franklin Electric
FELE
$4.67B
| $876K | 0.01% |
+17,152
| New | +$845K |
|
1173
Universal Display
OLED
$3.71B
| $876K | 0.01% |
5,734
+2,995
| +109% | +$371K |
|
1174
NMI Holdings
NMIH
$3.25B
| $872K | 0.01% |
33,701
+22,650
| +205% | +$517K |
|
1175
Ascendis Pharma A/S
ASND
$16.7B
| $869K | 0.01% |
7,379
+4,119
| +126% | +$361K |
|
Similar funds
Squarepoint's Q1 2019 Portfolio in Review
As of Q1 2019, Squarepoint held 2,631 positions worth $9.44B, up 9.9% from $8.59B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Squarepoint's Q1 2019 filing shows 740 new, 757 increased, 599 reduced and 531 closed positions. Its largest new stake was Starbucks: 1,112,290 shares worth $82.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $624M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Squarepoint's largest Q1 2019 buy was Starbucks: 1,112,290 shares worth $82.7M.
- Squarepoint added most to Dollar General in Q1 2019, an estimated $117M increase.
- Squarepoint's biggest Q1 2019 reduction was Allergan plc, cutting an estimated $85.5M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2019, selling an estimated $624M.
- Squarepoint's ten largest holdings make up 10% of its $9.44B portfolio in Q1 2019.
- Squarepoint opened 740 new positions and closed 531 in Q1 2019.
- Squarepoint's portfolio value rose 9.9% quarter-over-quarter to $9.44B.
Based on Squarepoint's 13F filing for Q1 2019, filed 15 May 2019.